Your session is about to expire
← Back to Search
Pilocarpine Ophthalmic Topical Cream, Dose 2 for Presbyopia
Study Summary
This trial is testing whether a cream containing the drug pilocarpine is safe and effective for treating presbyopia, a condition that causes difficulty reading up close.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this clinical research require additional participants?
"This research is currently seeking participants, with the first posting date on March 1st 2022 and a recent update made on May 11th 2022. This information can be found on clinicaltrials.gov"
Is my profile compatible with the prerequisites for taking part in this medical experiment?
"This medical trial is accepting patients aged 40-55 who suffer from presbyopia, with a total of 120 individuals required."
What medical purpose does Pilocarpine Ophthalmic Topical Cream, Dose 2 typically serve?
"Pilocarpine Ophthalmic Topical Cream, Dose 2 has the potential to remediate radiotherapy-related issues, miosis (constricted pupil), and presbyopia."
What is the total enrollment capacity for this medical research project?
"Correct. Clinicaltrials.gov affirms that this medical investigation, which was first made available on the 3rd of January 2022, is currently enrolling participants. Around 120 people need to be recruited from 10 distinct sites."
What potential risks have been associated with using Pilocarpine Ophthalmic Topical Cream, Dose 2?
"Based on the available evidence, our analysts have assigned a score of 2 to Pilocarpine Ophthalmic Topical Cream's safety profile. This is because this is a Phase 2 trial and there are data points that suggest its security but no efficacy studies exist yet."
Are individuals aged 40 and above being included in this experimentation?
"This study is seeking participants aged 40 years and above, but below 55."
Are there historical accounts of experiments with Pilocarpine Ophthalmic Topical Cream, Dose 2?
"Presently, there are 3 clinical trials for Pilocarpine Ophthalmic Topical Cream, Dose 2; one of which is at the final Phase 3 stage. While all studies take place in Glendale, California - 13 medical centres across the region are running tests and collecting data."
How many healthcare centers are actively participating in this trial?
"This clinical trial currently has 10 participating centres, located in cities such as Louisville, San Antonio and Sun City. It is recommended to choose the nearest site when enrolling in order to minimize travelling costs."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger